The first Evogene trade was made in Q3 2020.
Since then Jim Simons bought shares five more times and sold shares on eight occasions. The investor completely sold their stake between Q2 2023 and Q3 2024.
Avg closing price
Price range
Sold -4.47k shares
Q3 2024
Avg closing price
$4.30
Price range
$2.51
-
$6.70
Sold 0.2% shares (-10 shares)
Q2 2024
Avg closing price
$6.98
Price range
$6.12
-
$8.20
Sold 1.3% shares (-60 shares)
Q4 2023
Avg closing price
$0.63
Price range
$0.47
-
$0.88
Sold 61.6% shares (-7.28k shares)
Q2 2023
Avg closing price
$0.68
Price range
$0.56
-
$1.20
Increased shares by 31.8% (+2.85k shares)
Q1 2023
Avg closing price
$0.74
Price range
$0.59
-
$0.86
Sold 4.5% shares (-421 shares)
Q4 2022
Avg closing price
$0.70
Price range
$0.61
-
$0.81
Sold 63.7% shares (-16.5k shares)
Q3 2022
Avg closing price
$0.96
Price range
$0.73
-
$1.29
Sold 43.7% shares (-20k shares)
Q2 2022
Avg closing price
$0.98
Price range
$0.74
-
$1.33
Increased shares by 51.8% (+15.7k shares)
Q1 2022
Avg closing price
$1.35
Price range
$1.09
-
$1.83
Increased shares by 14.0% (+3.72k shares)
Q4 2021
Avg closing price
$2.27
Price range
$1.63
-
$2.83
Increased shares by 176.8% (+16.9k shares)
Q3 2021